Pathol Oncol Res. 1997;3(2):147-158. doi: 10.1007/BF02907812.
Pathology oncology research : POR
Adorján Aszalós, Sándor Eckhardt
PMID: 11173644 DOI: 10.1007/BF02907812
The aim of this review is to introduce some molecular targets for cancer chemotherapy, with comments on their mode of action, preclinical and clinical results. The representatives of the following groups are covered: phosphorylation inhibitors, protein kinase modulators, receptor antagonists, immunomodulators, differentiating agents, multidrug resistance modulation, telomerase inhibitors, and bioreductive agents.